Key result
GDMT achieves complete symptom resolution in a case of takotsubo cardiomyopathy with Parkinson's disease.
Why the study?
Literature remains limited regarding the interconnection between Parkinson's disease, coronary microvascular disease, and takotsubo cardiomyopathy.
Case Report (n=1)
No
This case highlights a rare presentation of Takotsubo cardiomyopathy in a male patient with Parkinson's disease and heroin abuse, suggesting a potential link between these conditions and coronary microvascular dysfunction.
Supports GDMT in Takotsubo with Parkinson's and heroin abuse; hypothesis-generating for coronary microvascular dysfunction as linking mechanism.
Takotsubo cardiomyopathy, in essence, is a reversible abnormality of the heart muscle resembling myocardial infarction in the absence of any disease of the coronary artery. A middle-aged man with medical history of Parkinson’s disease (PD) and substance abuse with heroin presents with chest pain. Apart from high blood pressure, he was haemodynamically stable. His troponins were elevated with a positive delta but had no ischemic changes on his electrocardiograms. He was treated as a non ST-segment elevated myocardial infarction (NSTEMI) and started on appropriate medications. His ejection fraction was found to be 35% and he had a large territory of the left ventricle apical akinesis. He was subsequently taken for a coronary angiogram which did not reveal any obstruction in his coronary arteries. This was deemed to be takotsubo cardiomyopathy and he was managed on Guideline Directed Medical Therapy. He was eventually discharged without any symptoms. Years of data have helped us gain insight into the etio-pathogenesis of this novel and rare condition, and although literature is limited, this case paves a path toward broadening our understanding about PD, coronary microvascular disease and takotsubo cardiomyopathy and their inter-connection.
No takes yet. Share an insight, caveat, or question.
Cooper et al. (2024) conducted a case report in Middle-aged man (56 years old) with Parkinson's disease and polysubstance abuse including heroin, presenting with acute chest pain and diagnosed with takotsubo cardiomyopathy (n=1). Guideline Directed Medical Therapy including carvedilol, dapagliflozin, sacubitril-valsartan, and spironolactone was evaluated on Resolution of chest pain and normalization of blood pressure with improvement in symptoms at discharge. Guideline Directed Medical Therapy led to complete symptom resolution and discharge without chest pain or elevated blood pressure in a 56-year-old male with Parkinson's disease and takotsubo cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: